Latest Cost Savings News

Starpharma reports steady progress in its DEP® drug development programs, launches new marketing campaigns in key regions, and maintains a strong cash position of $17.2 million as it refines clinical strategies and partnerships.

Althea Group Holdings reported $5.02 million in Q3 FY25 receipts, driven by strong growth at Peak Canada and the launch of Peak USA, while its pharmaceutical cannabis division faces steep revenue declines prompting strategic review.

Gratifii Limited reported a record quarterly cash receipt surge of 111% year-on-year, driven by key contract wins and successful platform migration despite cyclone disruptions. The company advances its post-merger integration and eyes an $84m revenue run rate in FY26.

Australian Vanadium Limited reports significant progress across its vertically integrated vanadium strategy, with key project milestones, government approvals, and promising energy storage developments positioning it for growth.

BirdDog Technology reported a slight 4.1% decline in Q3 FY25 sales to A$3.6 million while progressing strongly on its next-generation product roadmap and implementing significant cost reductions.

MAC Copper Limited reported steady Q1 2025 copper production amid rising costs but strengthened its balance sheet through a significant debt refinancing, positioning itself for a 23% production increase by 2026.

Lark Distilling Co. reported a robust Q3FY25 with net sales rising 31% to $4.3 million, driven by growth in travel retail, ecommerce, and exclusive whisky releases. The company also progressed its Pontville distillery redevelopment and maintained positive operating cash flow.

Control Bionics reports its strongest US revenue in years alongside Australia’s best quarter since 2022, propelled by new product launches and strategic investments.

Firebird Metals has made significant strides in its LMFP battery strategy, finalizing multiple offtake agreements with Chinese manufacturers and securing a mining lease for its Oakover project, positioning itself as a low-cost producer in the growing battery materials market.

Entertainment Rewards Ltd reports its strongest Q3 revenue in three years, driven by growth in Frequent Values and Paid Advertising, alongside a significant debt restructuring that reclassifies $22.5 million as equity.

OncoSil Medical has reported a remarkable 233% increase in dose sales for Q3 FY25, alongside significant regulatory approvals and strategic expansions that position the company for accelerated growth.

betr Entertainment has unveiled a revised $360 million proposal to acquire PointsBet, backed by a $130 million fully underwritten equity raise and promising $40 million in annual cost synergies. The offer aims to outmaneuver a competing bid and accelerate integration in the Australian wagering market.